Geriatric emergency medication safety recommendations: Difference between revisions
No edit summary |
No edit summary |
||
| Line 11: | Line 11: | ||
| | | | ||
*[[Epilepsy]] | *[[Epilepsy]] | ||
**Use other anticonvulsants | **Use other [[anticonvulsants]] | ||
**Examples: [[lamotrigine]], [[levetiracetam]]) | **Examples: [[lamotrigine]], [[levetiracetam]]) | ||
*[[Agitation]] | *[[Agitation]] | ||
| Line 26: | Line 26: | ||
*Examples: [[diazepam]], [[lorazepam]], [[midazolam]] | *Examples: [[diazepam]], [[lorazepam]], [[midazolam]] | ||
| | | | ||
*Epilepsy | *Epilepsy | ||
*Agitation | **Use other [[anticonvulsants]] | ||
**Examples: [[lamotrigine]], [[levetiracetam]] | |||
| | *Agitation | ||
*Seizure disorders | **Treat pain first with [[acetaminophen]] then low-dose [[opioid]] | ||
*Severe agitation | |||
**use nonpharmacologic approach then low-dose second-generation [[antipsychotic]] | |||
**Examples: [[olanzapine]], [[risperidone]], [[quetiapine]] (Lewy body dementia)| | |||
*Seizure disorders | |||
**[[Benzodiazepine withdrawal]] | |||
**[[Ethanol withdrawal]] | |||
**Severe generalized [[anxiety disorder]] | |||
**[[Palliative care]] | |||
|- | |- | ||
| First-generation [[antihistamines]] | | First-generation [[antihistamines]] | ||
Revision as of 20:47, 20 May 2026
High-Risk Medications to Avoid for Geriatric Patients at ED Discharge[1]
| High-Risk Therapeutic Class (AVOID) | Alternative Options (Preferred) | Valid Exceptions^ (Use with Caution) |
|---|---|---|
Barbiturates
|
|
|
| Benzodiazepines |
| |
First-generation antihistamines
|
|
|
| Metoclopramide |
|
|
| First-generation antipsychotics |
|
|
| Nonbenzodiazepine, Benzodiazepine Receptor Agonist Hypnotics (Z-drugs) |
|
|
| Skeletal muscle relaxants |
|
|
| Sulfonylureas | Metformin, long-acting insulin (eg, glargine). |
^Indications for use where high-risk medication benefit may outweigh risks.
See Also
- ↑ Skains, et al. Geriatric Emergency Medication Safety Recommendations (GEMS-Rx). Annals of Emergency Medicine. September 2024. 84(3):274-284. https://doi.org/10.1016/j.annemergmed.2024.01.033
